BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 7595899)

  • 1. Childhood tuberculosis and infection with the human immunodeficiency virus.
    Chintu C; Zumla A
    J R Coll Physicians Lond; 1995; 29(2):92-5. PubMed ID: 7595899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis and HIV-infection in developing countries.
    Broekmans JF
    Trop Geogr Med; 1991 Jul; 43(3):S13-21. PubMed ID: 1687768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality.
    Cantwell MF; Binkin NJ
    Tuber Lung Dis; 1996 Jun; 77(3):220-5. PubMed ID: 8758104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis and human immunodeficiency virus infection in developing countries.
    Harries AD
    Lancet; 1990 Feb; 335(8686):387-90. PubMed ID: 1968123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.
    Nunn PP; Elliott AM; McAdam KP
    Thorax; 1994 May; 49(5):511-8. PubMed ID: 8016777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.
    Narain JP; Raviglione MC; Kochi A
    Tuber Lung Dis; 1992 Dec; 73(6):311-21. PubMed ID: 1292709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
    Corbett EL; Watt CJ; Walker N; Maher D; Williams BG; Raviglione MC; Dye C
    Arch Intern Med; 2003 May; 163(9):1009-21. PubMed ID: 12742798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research issues involving HIV-associated tuberculosis in resource-poor countries.
    De Cock KM; Binkin NJ; Zuber PL; Tappero JW; Castro KG
    JAMA; 1996 Nov; 276(18):1502-7. PubMed ID: 8903262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.
    Dye C; Scheele S; Dolin P; Pathania V; Raviglione MC
    JAMA; 1999 Aug; 282(7):677-86. PubMed ID: 10517722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the HIV epidemic on tuberculosis control programmes in developing countries.
    Veeken H; Bermejo A
    Trop Doct; 1992 Apr; 22(2):64-7. PubMed ID: 1344023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2.
    Gnaore E; Sassan-Morokro M; Kassim S; Ackah A; Yesso G; Adjorlolo G; Digbeu H; Coulibaly D; Coulibaly IM; Doorly R
    Trans R Soc Trop Med Hyg; 1993; 87(1):57-9. PubMed ID: 8385370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
    Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D; Harries A; Getahun H
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis in HIV infection.
    Horner PJ; Moss FM
    Int J STD AIDS; 1991; 2(3):162-7. PubMed ID: 1863645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.